PMC:7594251 / 64112-64709
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T29116 | 283-290 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T464 | 509-510 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T465 | 528-529 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T466 | 569-570 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T143 | 53-64 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T53934 | 95-100 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T58239 | 104-118 | Chemical | denotes | pharmaceutical | http://purl.obolibrary.org/obo/CHEBI_52217 |
| T77617 | 139-145 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
| T41826 | 244-251 | Chemical | denotes | ligands | http://purl.obolibrary.org/obo/CHEBI_52214 |
| T43643 | 269-274 | Chemical | denotes | FK506 | http://purl.obolibrary.org/obo/CHEBI_61049 |
| T31095 | 283-290 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T95052 | 438-447 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T151 | 475-479 | Chemical | denotes | iodo | http://purl.obolibrary.org/obo/CHEBI_43448 |
| T152 | 482-500 | Chemical | denotes | methoxynaphthalene | http://purl.obolibrary.org/obo/CHEBI_48851 |
| T37296 | 556-564 | Chemical | denotes | cavitand | http://purl.obolibrary.org/obo/CHEBI_51027 |
| T97423 | 577-586 | Chemical | denotes | 4-pyridyl | http://purl.obolibrary.org/obo/CHEBI_51643 |
| T155 | 588-596 | Chemical | denotes | cavitand | http://purl.obolibrary.org/obo/CHEBI_51027 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 640 | 269-274 | Chemical | denotes | FK506 | MESH:D016559 |
| 641 | 449-468 | Chemical | denotes | p-ethoxyiodobenzene | |
| 642 | 473-500 | Chemical | denotes | 2-iodo-6-methoxynaphthalene | |
| 643 | 538-555 | Chemical | denotes | (4-hydroxyphenyl) |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T440 | 0-172 | Sentence | denotes | There are many examples demonstrating the successful application of diffusion NMR in examining drugs of pharmaceutical interest [305], and ligand-target interactions [167]. |
| T441 | 173-331 | Sentence | denotes | Hajduk et al. [167] exploited the changes in diffusion rates to detect ligands that bind to the FK506 binding protein and the catalytic domain of stromelysin. |
| T442 | 332-597 | Sentence | denotes | Nishimura et al. [306] utilized DOSY, in combination with NOESY to determine the orientation of two guest molecules, p-ethoxyiodobenzene and 2-iodo-6-methoxynaphthalene, within a host composed of a tetrakis(4-hydroxyphenyl)-cavitand and a tetra(4-pyridyl)-cavitand. |